Rho GTPase activating protein 16, pseudogene (ARHGAP16P)

ARHGAP16P is classified as a human pseudogene that resembles the functional gene ARHGAP16, which belongs to the family of Rho GTPase activating proteins (RhoGAPs). Unlike functional RhoGAPs, ARHGAP16P does not encode a protein, lacks functional domains, and has no known physiological or pathological significance[1][3][7]. Pseudogenes generally arise from gene duplication or retrotransposition events and are often transcriptionally silent or produce non-functional RNA. In contrast, bona fide RhoGAPs such as ARHGAP16 are involved in signaling pathways regulating cytoskeletal organization, cell motility, and immune modulation, and are sometimes implicated in cancer progression and immune processes[1][5][7]. However, these activities do not apply to ARHGAP16P. ARHGAP16P should not be considered a therapeutic target and is not a member of any canonical molecular or therapeutic classification.

Other names

Rho GTPase activating protein 16 pseudogene

Null. Mechanisms of action for interacting drugs are not relevant, as ARHGAP16P has no protein product.